Skip to main content

Table 1 Clinical and biological characteristics in coronary artery disease patients when they were first included in the GENES study

From: Serum levels of mitochondrial inhibitory factor 1 are independently associated with long-term prognosis in coronary artery disease: the GENES Study

  Alive (n = 407) Dead (n = 170) P
Age, years 59.5 (7.8) 62.9 (8.0) 0.03
School, years of education 9.7 (3.0) 9.2 (2.6) 0.03b
Smoking, pack year 31.3 (31.1) 49.3 (44.1) 0.001b
Alcohol, g/day 28.4 (31.6) 28.7 (29.6) 0.93
Physical activity (high level), % 14.3 5.3 0.003
Treatment for diabetes, % 19.4 36.5 0.001
Treatment for dyslipidemia, % 67.6 56.5 0.02
Treatment for hypertension, % 42.7 50.0 0.12
BMI, kg/m2 27.3 (3.8) 27.7 (4.4) 0.27
Waist circumference, cm 97.9 (10.0) 101.5 (12.7) 0.001
Systolic blood pressure, mm Hg 139.2 (20.1) 139.8 (22.0) 0.77
Heart rate, beats/min 62.2 (10.6) 67.1 (13.3) 0.001a
Fasting glucose, mmoL/L 5.69 (1.58) 6.41 (2.72) 0.06b
Triglycerides, g/L 1.66 (0.88) 1.57 (0.80) 0.17a
Total cholesterol, g/L 2.01 (0.41) 1.94 (0.43) 0.06
LDL-C, g/L 1.25 (0.35) 1.20 (0.39) 0.13
HDL-C, g/L 0.43 (0.12) 0.43 (0.11) 0.42
Lipoprotein(a) ≥ 0.30 vs. < 0.30 g/L, % 55.8 47.7 0.08
eGFR < 30 mL/min, % 0.5 4.7 0.002c
hs-CRP ≥ 5 mg/L vs. < 5 mg/L, % 51.6 64.1 0.006
hs-TnT, pg/mL 145.9 (386.2) 198.1 (469.1) 0.002b
NT-proBNP, pg/mL 383.3 (683.1) 1253.9 (2347.5) 0.001b
ABI ≤ 0.9, % 29.7 47.1 0.001
LVEF ≥ 50 %, % 77.2 49.4 0.001
Gensini score 43.8 (37.3) 57.3 (46.3) 0.003a
Duration of coronary artery disease, months 33.4 (57.2) 57.6 (73.2) 0.001b
IF1, mg/L 0.44 (0.12) 0.41 (0.13) 0.03
  1. Data are expressed in mean (SD) or %
  2. BMI body mass index, eGFR estimated Glomerular Filtration Rate, hs-CRP high-sensitivity C-Reactive Protein, hs-TnT high-sensitivity cardiac troponin T, NT-proBNP N-terminal pro-brain natriuretic peptide, ABI Ankle-brachial index, LVEF Left Ventricular Ejection Fraction
  3. alog transformed data, bWilcoxon–Mann–Whitney test, cFischer’s exact test